Recent advances in drug delivery systems for anti-diabetic drugs: A review

Current Drug Delivery

Volumn 11, Issue 4, 2014, Pages 444-457

  Grover, Meenu ^a   Utreja, Puneet ^a  

^a PCTE Institute of Pharmacy   (India)

Author keywords

Conventional therapy; Diabetics; Marketed formulations; Novel Drug Delivery Systems; Oral hypoglycemics; Sustained release

Indexed keywords

2,4 THIAZOLIDINEDIONE DERIVATIVE; ALPHA GLUCOSIDASE INHIBITOR; ANTIDIABETIC AGENT; BIGUANIDE DERIVATIVE; GLIBENCLAMIDE; GLICLAZIDE; GLIPIZIDE; MEGLITINIDE; METFORMIN; MICROSPHERE; NANOPARTICLE; NATEGLINIDE; NIOSOME; PIOGLITAZONE; POLYMER; REPAGLINIDE; ROSIGLITAZONE; DELAYED RELEASE FORMULATION;

CONTROLLED DRUG RELEASE; DRUG BIOAVAILABILITY; DRUG CAPSULE; DRUG DELIVERY SYSTEM; DRUG DOSAGE FORM; DRUG HALF LIFE; HUMAN; HYDROGEL; HYPOGLYCEMIA; NANOTECHNOLOGY; NONHUMAN; PARTICLE SIZE; PRIORITY JOURNAL; REVIEW; SUSTAINED DRUG RELEASE; TABLET; TRANSDERMAL DRUG ADMINISTRATION; TRANSDERMAL PATCH; ADMINISTRATION AND DOSAGE; ANIMAL; COMPLICATION; DELAYED RELEASE FORMULATION; DIABETES COMPLICATIONS; DIABETES MELLITUS, TYPE 1; DIABETES MELLITUS, TYPE 2; THERAPEUTIC USE; TRENDS;

ANIMALS; DELAYED-ACTION PREPARATIONS; DIABETES COMPLICATIONS; DIABETES MELLITUS, TYPE 1; DIABETES MELLITUS, TYPE 2; DRUG DELIVERY SYSTEMS; HUMANS; HYPOGLYCEMIC AGENTS;

EID: 84904760972     PISSN: 15672018     EISSN: 18755704     Source Type: Journal    
DOI: 10.2174/1567201811666140118225021     Document Type: Review

References (100)

1. The global diabetes community. http://www. diabetes. co. uk/globaldiabetes/index. html (Accessed September 1, 2012).
2. Bastaki, S. Diabetes mellitus and its treatment. Int. J. Diabetes. Metab., 2005, 13, 111-134.
3. th Ed.; Jaypee Brothers: New Delhi, 2008.
4. Kahn, S. E. The relative contributions of insulin resistance and betacell dysfunction in the pathophysiology of type 2 diabetes. Diabetologia., 2008, 46, 3-19.
5. Ahmad, L. A.; Crandall, J. P. Diabetes prevention: a review. Clin. Diabetes., 2010, 28, 53-59.
6. Kastorini, C. M.; Panagiotakos, D. B. Dietary patterns and prevention of type 2 diabetes: from research to clinical practice; a systematic review. Curr. Diabetes. Rev., 2009, 5, 221-227.
7. Patel, J. K.; Patel, R. P.; Amin, A. F.; Patel, M. M. Formulation and evaluation of mucoadhesive glipizide microspheres. AAPS. Pharm. Sci. Tech., 2005, 6, E49-E55.
8. Rawat, M. K.; Jain, A.; Mishra, A.; Muthu, M. S.; Singh, S. Development of repaglinide loaded solid lipid nanocarrier: selection of fabrication method. Curr. Drug Del., 2010, 7, 44-50.
9. Kavitha, K.; Puneeth, K. P.; Tamizh, M. T. Development and evaluation of rosiglitazone maleate floating tablets. Int. J. App. Pharm., 2010, 2, 6-10.
10. Dhana Lekshmi, U. M.; Poovi, G.; Kishore, N.; Reddy, P. N. In vitro characterization and in vivo toxicity study of repaglinide loaded poly methyl methacrylate nanoparticles. Int. J. Pharm., 2010, 396, 194-203.
11. Gupta, V. N.; Shivakumar, H. G. Preperation and characterisation of superporous hydrogels as gastroretensive drug delivery system for rosiglitazone maleate. J. Pharm. Sci., 2010, 18, 200-209.
12. Vaghani, S. S.; Patel, M. M. Hydrogels based on interpenetrating network of chitosan and polyvinyl pyrrolidone for pH-sensitive delivery of repaglinide. Curr. Drug. Discov. Technol., 2011, 8, 126-35.
13. Mathew, S. T.; Devi, G. S.; Prasanth, V. V.; Vinod, B. NSAIDs as microspheres. Internet. J. Pharmacol., 2008, 6.
14. Rao, S. B.; Sharma, C. P. Use of chitosan as biomaterial: studies on its safety and haemostatic potential. J. Biomed. Mat. Res., 1997, 34, 21-28.
15. Lehr, C. M.; Bouwstra, J. A.; Schacht, E. H.; Junginger, H. E. In vitro evaluation of mucoadhesive properties of chitosan and some other natural polymers. Int. J. Pharm., 1992, 78(1-3), 43-48.
16. Henriksen, L.; Green, K. L.; Smart, J. D.; Smistad, G.; Karlsen, J. Bioadhesion of hydrated chitosans: an in vitro and in vivo study. Int. J. Pharm., 1996, 145, 231-240.
17. Chowdary, K. P. R.; Rao, Y. S. Design and in vitro and in vivo evaluation of mucoadhesive microcapsules of glipizide for oral controlled release: a technical note. AAS Pharm. Sci. Tech., 2003, 4, 87-92.
18. Chowdary, K. P. R.; Srinivas, L. Mucoadhesive drug delivery systems: a status of current review. Indian Drugs, 2000, 37, 400-406.
19. Jain, S. K.; Agrawal, G. P.; Jain, N. K. A novel calcium silicate based microspheres of repaglinide: in vivo investigations. J Control Release., 2006, 113(2), 111-116.
20. Attama, A. A.; Nwabunze, O. J. Mucuna gum microspheres for oral delivery of glibenclamide: In vitro evaluation. Acta. Pharma., 2007, 57, 161-171.
21. Balasubramaniam, J.; Rao, V. U.; Vasudha, M.; Babu, J.; Rajinikanth, P. S. Sodium alginate microspheres of metformin hydrochloride: formulation and in vitro evaluation. Curr. Drug. Deliv., 2007, 4, 249-56.
22. Raida, S.; Kassas, A.; Gohary, A.; Monirah, M.; Faadhel, A. Controlling of systemic absorption of gliclazide through incorporation into alginate beads. Int. J. Pharm., 2007, 341, 230-237.
23. Phutane, P.; Shidhaye, S.; Lotlikar, V.; Ghule, A.; Sutar, S.; Kadam, V. In vitro evaluation of novel sustained release microspheres of glipizide prepared by the emulsion solvent diffusion evaporation method. J. Young. Pharm., 2010, 2, 35-41.
24. Reddy, K. K.; Narasimharao, R.; Jagadeeshbabu, V.; Reddy, C. Formulation and evaluation of metformin HCL microspheres. Int. J. Pharm. Tech., 2011, 3, 2228-2247.
25. Gangadharappa, H. V.; Srirupa, B.; Getyala, A.; Gupta, V. N.; Pramod, K. T. M. Development, in vitro and in vivo evaluation of novel floating hollow microspheres of rosiglitazone maleate. Der. Pharmacia. Lettre., 2011, 3, 299-316.
26. Mallick, J.; Sahoo, D.; Kar, D. M.; Reddy, S. K.; Sahoo, D. Formulation, evaluation and in vitro-in vivo correlation of sustained release glipizide microspheres. Pharm. Sci. Monitor., 2013, 4(3), 90-99.
27. Sharma, H. K.; Lahkar, S.; Kantanath, L. Formulation and in vitro evaluation of metformin hydrochloride loaded microspheres prepared with polysaccharide extracted from natural sources. Acta. Pharm., 2013, 63(2), 209-222.
28. Nayak, A. K.; Pal, D. K.; Santra, K. Plantago ovate F. mucilage alginate mucoadhesive beads for controlled release of glibenclamide: development, optimisation and in vitro in vivo evaluation. J Pharmaceutics. 2013, doi: 10. 1155/2013/151035.
29. Raval, V.; Sailor, G.; Seth, A. K.; Chauhan, S. K. P. Formulation and evaluation of gastroretentive drug delivery system of gliclazide. Pharm. Sci. Monitor., 2013, 4(1), 214-230.
30. Bashir, S.; Nazir, I.; Khan, H.; Alamgeer; Asad, M.; Hassnain, F.; Qamar, S. Formulation and in vitro evaluation of nateglinide microsphere using HPMC and carbopol-940 polymers by ionic gelation method. Pak. J. Pharm. Sci., 2013, 26(6), 1229-1235.
31. Mohanraj, V. J.; Chen, Y. Nanoparticles: A review. Trop. J. Pharm. Res., 2006, 5, 561-573.
32. Parashar, U. K.; Kesharwani, V.; Saxena, P. S.; Srivatava, A. Role of nanomaterials in biotechnology. Digest J. Nanomat. Biostruct., 2008, 3, 81-87.
33. Cetin, M.; Atila, A.; Sahin, S.; Vural, L. Preparation and characterization of metformin hydrochloride loaded Eudragit® RSPO and Eudragit® RSPO/PLGA nanoparticles. Pharmaceut. Dev. Tech., 2011, 18, 570-576.
34. Sharma, N.; Bansal, M.; Visht, S.; Sharma, P. K.; Kulkarni, G. T. Nanoemulsions: a new concept of drug delivery system. Chron. Young. Sci., 2010, 2, 2-6.
35. Jain, N. K.; Ram, A. Development and characterization of nanostructured lipid carriers of oral hypoglycemic agent: selection of surfactants. Int. J. Pharm. Sci. Rev. Res., 2011, 7(2), 125-130.
36. Jain, S.; Saraf, S. Repaglinide loaded long circulating biodegredable nanoparticles: rational approach for the management of type 2 diabetes mellitus. J. Diabetes, 2009, 1, 29-35.
37. Dora, C. P.; Singh, S. K.; Kumar, S.; Datusalia, A. K.; Deep, A. Development and characterization of nanoparticles of glibenclamide by solvent displacement method. Acta. Poloniae. Pharmaceutica., 2010, 67, 283-290.
38. Mulla, J. A. S.; Hiremath, S. P.; Sharma, N. K. Repaglinide loaded solid lipid nanoparticles: design and characterization. RJUHS J. Pharm. Sci., 2012, 2(4), 41-49.
39. Srilatha, R.; Aparna, C.; Srinivas, P.; Sadanandam, M. Formulation, evaluation and characterization of glipizide nanoemulsion. Asian. J. Pharm. Clin. Res., 2013, 6(2), 66-71.
40. Blanco, M. D.; Garcia, O.; Trigo, R. M.; Teijon, J. M.; Katime, I. 5-Fluorouracil release from copolymeric hydrogels of itaconic acid monoester. I. Acrylamide-co-monomethyl itaconate. Biomaterials., 1996, 17, 1061-1067.
41. Satish, C. S.; Satish, K. P.; Shivakumar, H. G. Hydrogels as controlled drug delivery systems: synthesis, crosslinking, water and drug transport mechanism. Indian J. Pharm. Sci., 2006, 68(2), 133-140.
42. Gupta, N.; Satish, C.; Shivakumar, H. Preperation and characterisation of gelatin-poly(methacrylic acid) interpenetrating polymeric network hydrogels as a pH-sensetive delivery system for glipizide. Indian J. Pharmacl. Sci., 2007, 69, 64-68.
43. Sun, P.; Li, P.; Li, Y. M.; Wei, Q.; Tian, L. H. A pH sensitive chitosan tripolyphosphate hydrogel beads for controlled glipizide delivery. J. Biomed. Mater. Res. B Appl. Biometer., 2011, 97, 175-83.
44. Inayat, P. B.; Setty, M. C. Chemical penetration enhancers for transdermal drug delivery systems. Trop. J. Pharm. Res., 2009, 8, 173-179.
45. Kandavilli, S.; Nair, V.; Panchgnula, R. Polymers in transdermal drug delivery systems. Pharmtech., 2002, 26(2), 62-80.
46. Naik, A.; Kalia, Y. N.; Guy, R. H. Transdermal drug delivery: overcoming the skin's barrier function. Pharm. Sci. Technol. Today, 2000, 3, 318-326.
47. Benson, H. A. E. Transdermal drug delivery: penetration enhancement techniques. Curr. Drug Deliv., 2005, 2, 23-33.
48. Mutalik, S.; Udupa, N. Glibenclamide transdermal patches: physicochemical, pharmacodynamic, and pharmacokinetic evaluations. J. Pharm. Sci., 2004, 93, 1577-94.
49. Mishra, K. M.; Ray, D.; Barik, B. B. Microcapsules and transdermal patch: a comparative approach for improved delivery of antidiabetic drug. AAPS Pharm. Sci. Tech., 2009, 10, 928-934.
50. Patel, M.; Naruka, P. S.; Patel, M. M.; Patel, K. N. Formulation and evaluation of glibenclamide transdermal patches. The Indian Pharmacist, 2009, 8, 63-66.
51. Gupta, J. R. D.; Irchhiaya, R.; Garud, N.; Tripathi, P.; Dubey, P.; Patel, J. R. Formulation and evaluation of matrix type patches of glibenclamide. Int. J. Pharm. Sci. Res., 2009, 1, 46-50.
52. Das, A.; Ghosh, S.; Dey, B. K.; Das, S. A novel technique for treating the type-2 diabetes by transdermal patches prepared by using multiple polymer complexes. Int. J. Pharm. Res. Dev., 2010, 2, 195-204.
53. Hasan, M. K.; Rahman, M. A.; Shahin, S. M.; Ul Islam, M. A. In Vitro and In Vivo evaluation of a rosiglitazone maleate-loaded HPMC-PVA blend patch. BPJ., 2010, 13, 60-63.
54. Pillai, S. S.; Kumar, K. L. S.; Panneerselvam, T.; Shabaraya, A. R.; Muneer, T. K. Effect of polymeric activity on transdermal patches of glipizide. RIP., 2011, 1, 1-5.
55. Anitha, P.; Ramkanth, S.; Saleem, M. T. Preparation, in vitro and in vivo characterization of transdermal patch containing glibenclamide and atenolol: a combinational approach. Pak. J. Pharm. Sci., 2011, 24, 155-63.
56. Allena, R. T,; Yadav, H. K. S.; Sandina, S.; Prasad, S. C. Preperation and evaluation of transdermal patches of metformin hydrochloride using natural polymer for sustained release. Int. J. Pharm. Pharm. Sci., 2012, 4, 297-302.
57. Pachisia, N.; Agrawal, S. S. Formulation, development and evaluation of transdermal drug delivery system of Glimepiride. Int. J. Pharm. Pharm. Sci. Res., 2012, 2, 1-8.
58. Kalva, S.; Sirse, K.; Raga, S. R. Design and evaluation of transdermal drug delivery system of glipizide using natural and synthetic polymers. Int. J. Pharm. Res. Dev., 2013, 5(9), 89-94.
59. Samifer, S.; Naveen, G.; Naik, V. V.; Mahathi, K.; Kumar, G. D. Design and development of glipizide matrix transdermal patches with Eudragit RLPO polymer. Int. J. Pharm. Chem. Sci., 2013, 2(4), 1852-1856.
60. Kumar, V.; Prajapati, S. K.; Soni, G. C.; Singh, M.; Kumar, N. Sustained release matrix type drug delivery system: a review. W. J. Pharmacy and Pharma. Sci., 2012, 1, 934-960.
61. Makino, C.; Sakai, H.; Okano, A.; Yabuki, A. Design of nateglinide controlled release tablet containing erosion matrix tablet and multiple administration study in normal beagle dogs. Chem. Pharm. Bull. (Tokyo), 2009, 57, 907-13.
62. Kumar, G.; Juyal, V.; Badoni, P. P. Formulation and evaluation of matrix tablets of acarbose. Drug Inven. Today, 2010, 2, 264-267.
63. Marikanti, R. A.; Kiran K. I.; Nagaraju, T.; Laxmi Sowjanya, B.; Srikanth, G.; Venkateshwarlu, S. P. Design and in vitro evaluation of drug release and bioadhesive properties from bucoadhesive tablets of glibenclamide for systemic delivery. J. Chem. Pharm. Res., 2010, 2, 291-303.
64. Bao, Y. Q.; Zhou, J.; Zhou, M.; Cheng, Y. J.; Lu, W.; Pan, X. P.; Tang, J. L.; Lu H. J.; Jia, W. P. Glipizide controlled release tablets, with or without acarbose, improve glycaemic variability in newly diagnosed type 2 diabetes. Clin. Exp. Pharmacol. Physiol., 2010, 37, 564-568.
65. Mohd, A. H.; Babu V. L.; Pal, N. Formulation and evaluation of sustained release matrix tablets of glimepiride based on combination of hydrophilic and hydrophobic polymers. J. App. Pharm. Sci., 2012, 2, 101-107.
66. Tack, O. O.; Kim, J. Y.; Jung, M. H.; Sang, C. C.; Yun, S. R.; Chun, W. P. Preparation of highly porous gastroretentive metformin tablets using a sublimation method. Eur. J. Pharm. Biopharm., 2013, 83, 460-467.
67. Gouthami, T. G.; Jhansipriya, M. V.; Naidu, N. Effect of different polymers on release of the sustained release tablets of the glipizide. J. Chem. Pharm. Res., 2013, 5(5), 111-118.
68. Seth, M.; Goswami, D. S.; Dhaliwal, H.; Uppal, N.; Kashyap, S.; Sharma, K. D. Design and characterisation of floating tablets of Anti-Diabetic drug. Int. J. Res. Pharm. Chem., 2013, 3(3), 605-611.
69. Mujoriya, R. J.; Dhamande, K.; Bodla R. M. Niosomal drug delivery system-a review. Int. J. App. Pharm., 2011, 3, 7-10.
70. Kemps, J.; Crommelin, D. A. Hydrolyse van fosfolipiden in watering milieu. Pharm. Weekbl., 1988, 123, 355-363.
71. Yadav, J. D.; Kulkarni, P. R.; Vaidya, K. A.; Shelke, G. T. Niosomes: A Review. J. Pharm. Res., 2011, 4, 632-636.
72. Malhotra, M.; Jain, N. K. Niosomes as drug carriers. Indian Drugs., 1994, 31, 81-86.
73. Baillie, A. J.; Florence, A. T.; Hume, L. R.; Muirhead, G. T.; Rogerson, A. The preparation and properties of niosomes-non-ionic surfactant vesicles. J. Pharm. Pharmacol., 1985, 37, 863-868.
74. Rogerson, A. The distribution of doxorubicin in mice following administration in niosomes. J. Pharm. Pharmacol., 1988, 40, 337-342.
75. Baillie, A. J.; Coombs, G. H.; Dolan, T. F. Non-ionic surfactant vesicles, niosomes, as delivery system for the anti-leishmanial drug, sodium stribogluconate. J. Pharm. Pharmacol., 1986, 38, 502-505.
76. Khandare, J. N.; Madhavi, G.; Tamhankar, B. M. Niosomes novel drug delivery system. Eastern Pharmacist., 1994, 37, 61-64.
77. Tamizharasi, S.; Dubey, A.; Rathi, V.; Rathi, J. C. Development and characterization of niosomal drug delivery of gliclazide. J. Young. Pharm., 2009, 1, 205-209.
78. Hasan, A. A.; Madkor, H.; Wakeh, S. Formulation and evaluation of metformin hydrochloride loaded niosomes as controlled release drug delivery system. Drug Deliv., 2013, 20(3), 120-126.
79. Miro, A.; Quaglia, F.; Sorrentino, U.; Rotonda, M.; Bianca, R.; Sorrentino, R. Improvement of gliquidone hypoglycemic effect in rats by cyclodextrin formulations. Eur. J. Pharm. Sci., 2004, 23, 57-64.
80. Patil, S. A.; Kuchekar, B. S.; Chabukswar, A. R.; Jagdale, S. C. Formulation and evaluation of extended release solid dispersion of metformin hydrochloride. J. Young. Pharm., 2010, 2, 121-129.
81. Jagdale, S. C.; Patil, S. A.; Kuchekar, B. S.; Chabuksawar, A. R. Preparation and characterisation of metformin hydrochloridecompritol 888 ATO solid dispersion. J. Young. Pharm., 2011, 3, 197-204.
82. Thedu. in-Medicines. Usage/side effects. http://thedu. in/compare_prices/index. php/medicines-a/article/2069-afdiex-5mg-glibenclamide-tablet (Accessed September 8, 2012).
83. Healthfact in medicines and health. http://healthfact. in/index. php/medicine-price-list-1/article/16583-betanase-5-mg-cadila-healthcareltd-zydus-cadila-healthcare-ltd-tablet (Accessed September 8, 2012).
84. Cadila Pharmaceuticals Limited. The Care Continues. http://www. cadilapharma. com/index. php?option=com_content &view=article&id=513%3Aglyloc-40&catid=113%3Aoralhypoglycemic-agents&Itemid=189 (Accessed September 8, 2012).
85. Thedu. in-Medicines. Usage/side effects. http://thedu. in/compare_prices/index. php/medicines-d/article/25699-diaglip-5-mg-glipizide-tablet (Accessed September 8, 2012).
86. Dawa Bazar. Accelerating the pharma trade in India. http://www. dawabazar. in/eurepa_1mg/torrent_group_torrent_phar maceuticals_ltd/19187399 (Accessed September 8, 2012).
87. Healthkartplus. Your online pharmacy and drug database. http://www. healthkartplus. com/details/drugs/30581/repide-1-mg; jsessionid=fKPYzZToIxsf5jCYm7Zjq2-b. undefined (Accessed September 8, 2012).
88. Drugs Update. Com. Solutions for Healthcare Professionals/India. http://www. drugsupdate. com/brand/generic/Nateglinide/2149 (Accessed September 8, 2012).
89. Cadila Pharmaceuticals Limited. The Care Continues. http://www. cadilapharma. com/index. php?option=com_content &view=article&id=511%3Ainsumet-500-&catid=113%3Aoralhypoglycemic-agents&Itemid=189 (Accessed September 8, 2012).
90. Drug Information. http://kelo. in/drugs/cnd-zydus-cadila-healthcareltd/glizone-15-mg/(Accessed September 8, 2012).
91. Generic Pedia-Encyclopedia of Generic Drugs. http://www. genericpedia. com/brand/Reglit-2-mg/(Accessed September 8, 2012).
92. Dawa Bazar. Accelerating the pharma trade in India. http://www. dawabazar. in/claz_od_30mg/franco_indian_pharmaceu tical/26212799 (Accessed December 3, 2012).
93. Drugs Update. Com. Solutions for Healthcare Professionals/India. http://www. drugsupdate. com/brand/generic/Gliclazide/31585 (Accessed December 3, 2012).
94. Generic Pedia-Encyclopedia of Generic Drugs. http://www. genericpedia. com/brand/Azukon-MR-30-mg/(Accessed December 3, 2012).
95. Serdia Pharmaceuticals (India) Pvt Ltd. http://www. serdiapharma. com/about/diamicron. asp (Accessed December 3, 2012).
96. Thedu. in-Medicines. Usage/side effects. http://thedu. in/compare_prices/index. php/medicines-g/article/38597-glizid-mr-30-mggliclazide-tablet (Accessed December 4, 2012).
97. Drug Information. http://kelo. in/drugs/dr-reddy-laboratoriesltd/reclide-mr-30-mg/(Accessed December 4, 2012).
98. The Pharmacy express. com. http://www. thepharmacyexpress. com/Products2. asp?Brand=Glynase+XL+%28+Glucotrol+XL%2C+ Generic+Glipizide+%29&T=d (Accessed December 4, 2012).
99. Drugs Update. Com. Solutions for Healthcare Professionals/India. http://www. drugsupdate. com/brand/generic/Metformin/1827 (Accessed December 4, 2012).
100. Thedu. in-Medicines. Usage/side effects. http://thedu. in/compare_prices/index. php/medicines-e/article/32782-exermet-500-mgmetformin-tablet (Accessed December 4, 2012).